PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 9 days 4 hours 15 minutes
Antimicrobial Resistant Infections in the Acute Care Setting: Prevalence, Consequences, and Prevention Strategies
Go online to www.peervoice.com/h/pve50 to view the entire programme with slides.
Originators, Generics, and Biosimilars: How They Are Assessed
Originators, Generics, and Biosimilars: How They Are Assessed
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?
State of the Science in CKD: New Treatment, New Outcomes
State of the Science in CKD: New Treatment, New Outcomes
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
Scoping Out Optimal Antiviral Therapy for Patients With COVID-19: Exploring the Implications of the Latest Data
Scoping Out Optimal Antiviral Therapy for Patients With COVID-19: Exploring the Implications of the Latest Data
Taking the Sting Out of Hyperkalaemia: What Clinicians Can Do Now
Taking the Sting Out of Hyperkalaemia: What Clinicians Can Do Now